EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -0.1759
March 31, 2026 -0.2868
December 31, 2025 -0.4547
September 30, 2025 -0.3855
June 30, 2025 -0.4149
March 31, 2025 0.4868
December 31, 2024 -1.192
September 30, 2024 -0.5744
June 30, 2024 -0.3468
March 31, 2024 -0.4792
December 31, 2023 -0.8594
September 30, 2023 -3.038
June 30, 2023 -3.418
March 31, 2023 -3.504
December 31, 2022 18.52
September 30, 2022 -5.198
June 30, 2022 -8.293
March 31, 2022 -10.35
Date Value
December 31, 2021 -23.40
September 30, 2021 -40.06
June 30, 2021 -24.31
March 31, 2021 -21.30
December 31, 2020 -21.81
September 30, 2020 -15.17
June 30, 2020 -7.418
March 31, 2020 1.954
December 31, 2019 -19.50
September 30, 2019 -13.49
June 30, 2019 -17.65
March 31, 2019 -17.88
December 31, 2018 -16.08
September 30, 2018 -19.23
June 30, 2018 -25.50
March 31, 2018 -21.00
December 31, 2017 -13.14
September 30, 2017 -167.91

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Tenax Therapeutics, Inc. -0.35
Century Therapeutics, Inc. -0.1679
Absci Corp. -0.2109
Celularity, Inc. 0.0223
Cardio Diagnostics Holdings, Inc. -0.5073

EPS Diluted (Quarterly) Related Metrics